Kalkine has a fully transformed New Avatar.

Last update at 2026-03-10T16:47:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
May 2025 UK Stocks Priced Below Estimated Intrinsic Value
Wed 07 May 25, 06:37 AMUK Stocks That Might Be Trading Below Their Estimated Value In March 2025
Fri 07 Mar 25, 06:07 AM3 UK Stocks Estimated To Be Undervalued By Up To 48.1%
Thu 06 Mar 25, 06:07 AM3 UK Stocks Estimated To Be Trading Below Intrinsic Value By Up To 40.5%
Tue 04 Mar 25, 06:08 AMUK Stocks Trading At Estimated Discounts: A Trio Of Value Opportunities
Mon 03 Mar 25, 06:07 AMTrending tickers: Microsoft, Tesla, Wizz Air and Dr. Martens
Thu 25 Jan 24, 09:37 AMDr. Martens Insiders Placed Bullish Bets Worth UK£419.0k
Tue 23 Jan 24, 12:48 PMDr. Martens (LON:DOCS) Is Due To Pay A Dividend Of £0.0156
Wed 03 Jan 24, 05:28 AMDeclining Stock and Solid Fundamentals: Is The Market Wrong About Dr. Martens plc (LON:DOCS)?
Mon 25 Dec 23, 10:12 AMDr. Martens (LON:DOCS) Has Affirmed Its Dividend Of £0.0156
Sun 03 Dec 23, 07:22 AM| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Income before tax | 159.40M | 214.30M | 70.90M | 101.00M | 28.90M |
| Minority interest | - | - | - | - | - |
| Net income | 128.90M | 181.20M | 35.70M | 74.80M | 17.20M |
| Selling general administrative | - | - | 259.00M | 259.00M | 192.60M |
| Selling and marketing expenses | - | - | 259.00M | 259.00M | 192.60M |
| Gross profit | 618.10M | 578.80M | 470.50M | 401.50M | 260.60M |
| Reconciled depreciation | 54.20M | 36.90M | 29.50M | 29.50M | 10.60M |
| Ebit | 180.80M | 228.10M | 195.60M | 141.70M | 67.20M |
| Ebitda | 235.00M | 265.00M | 225.10M | 171.20M | 77.80M |
| Depreciation and amortization | 54.20M | 36.90M | 29.50M | 29.50M | 10.60M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 190.80M | 226.50M | 112.50M | 142.50M | 68.00M |
| Other operating expenses | 809.50M | 682.20M | 583.80M | 529.70M | 386.40M |
| Interest expense | 17.50M | 13.80M | 38.70M | 40.70M | 38.30M |
| Tax provision | 30.50M | 33.10M | 35.20M | 26.20M | 11.70M |
| Interest income | 1.90M | - | 41.60M | 41.50M | 39.10M |
| Net interest income | -16.80000M | -15.00000M | -41.60000M | -41.50000M | -39.10000M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 30.50M | 33.10M | 35.20M | 26.20M | 11.70M |
| Total revenue | 1000.30M | 908.30M | 773.00M | 672.20M | 454.40M |
| Total operating expenses | 427.30M | 352.70M | 281.30M | 259.00M | 192.60M |
| Cost of revenue | 382.20M | 329.50M | 302.50M | 270.70M | 193.80M |
| Total other income expense net | -31.40000M | -12.20000M | -119.40000M | -54.60000M | -39.10000M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 128.90M | 181.20M | 35.70M | 74.80M | 17.20M |
| Net income applicable to common shares | - | 181.20M | 34.70M | 74.80M | 17.20M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Total assets | 992.60M | 859.10M | 652.80M | 656.50M | 450.20M |
| Intangible assets | 24.90M | 21.40M | 20.10M | 16.50M | 11.10M |
| Earning assets | - | - | - | - | - |
| Other current assets | 14.70M | 16.70M | 9.00M | 14.50M | 53.20M |
| Total liab | 588.40M | 530.90M | 502.10M | 586.00M | 458.60M |
| Total stockholder equity | 404.20M | 328.20M | 150.70M | 70.50M | -8.40000M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 100.30M | 102.60M | 99.70M | 97.30M | 33.00M |
| Common stock | 10.00M | 10.00M | 10.00M | - | - |
| Capital stock | 10.00M | 10.00M | 10.00M | 0.00000M | 0.00000M |
| Retained earnings | 1782.20M | 1711.30M | 1538.10M | 224.70M | 170.10M |
| Other liab | - | 1.90M | 1.60M | 1.50M | 6.60M |
| Good will | 240.70M | 240.70M | 240.70M | 240.70M | 240.70M |
| Other assets | - | 9.60M | 7.40M | 7.40M | 6.00M |
| Cash | 157.50M | 228.00M | 113.60M | 117.20M | 58.40M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 164.50M | 155.00M | 152.30M | 130.70M | 64.50M |
| Current deferred revenue | -34.10000M | -19.80000M | -18.20000M | -41.80000M | - |
| Net debt | 294.30M | 165.80M | 252.80M | 65.50M | 15.90M |
| Short term debt | 34.10M | 19.80M | 18.20M | 41.80M | 3.20M |
| Short long term debt | 6.00M | - | - | 20.00M | 3.20M |
| Short long term debt total | 451.80M | 393.80M | 366.40M | 182.70M | 74.30M |
| Other stockholder equity | -1388.00000M | -1393.10000M | -1397.40000M | -154.20000M | -178.50000M |
| Property plant equipment | - | 143.80M | 110.00M | 114.70M | 26.90M |
| Total current assets | 508.80M | 443.60M | 274.80M | 277.20M | 165.50M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | 66.10M | -109.90000M | -186.70000M | -260.20000M |
| Short term investments | - | - | - | - | - |
| Net receivables | 78.80M | 75.90M | 50.70M | 55.50M | 48.90M |
| Long term debt | 293.40M | 280.90M | 281.60M | 74.30M | 71.10M |
| Inventory | 257.80M | 123.00M | 101.50M | 90.00M | 53.90M |
| Accounts payable | 64.20M | 52.40M | 52.60M | 33.40M | 20.00M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | - | - | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 1.00M | -405.90000M | -369.60000M | -371.90000M | - |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 483.80M | 415.50M | 378.00M | 379.30M | 284.70M |
| Capital lease obligations | 152.40M | 112.90M | 84.80M | 88.40M | 0.00000M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Investments | -50.60000M | -25.00000M | -21.90000M | -21.90000M | -17.10000M |
| Change to liabilities | 0.00000M | -1.00000M | 51.20M | 35.70M | 11.70M |
| Total cashflows from investing activities | - | -25.00000M | -17.30000M | -21.90000M | -17.10000M |
| Net borrowings | - | -24.00000M | 183.50M | -3.60000M | -4.10000M |
| Total cash from financing activities | -99.50000M | -47.00000M | -44.00000M | -44.00000M | -69.30000M |
| Change to operating activities | - | - | - | - | - |
| Net income | 128.90M | 181.20M | 74.80M | 74.80M | 17.20M |
| Change in cash | -70.50000M | 114.40M | 58.80M | 58.80M | -28.00000M |
| Begin period cash flow | 228.00M | 113.60M | 58.40M | 58.40M | 86.40M |
| End period cash flow | 157.50M | 228.00M | 117.20M | 117.20M | 58.40M |
| Total cash from operating activities | 77.30M | 184.40M | 121.40M | 121.40M | 56.00M |
| Issuance of capital stock | - | 0.00000M | 37.80M | - | - |
| Depreciation | 54.20M | 36.90M | 29.50M | 29.50M | 10.60M |
| Other cashflows from investing activities | - | - | - | - | - |
| Dividends paid | 58.40M | 12.20M | 51.30M | 12.20M | 12.20M |
| Change to inventory | -133.20000M | -18.30000M | -36.10000M | -36.10000M | -14.10000M |
| Change to account receivables | -6.60000M | -23.30000M | 0.80M | -16.60000M | -10.00000M |
| Sale purchase of stock | - | -35.00000M | -35.00000M | -35.00000M | -60.00000M |
| Other cashflows from financing activities | -12.00000M | -14.30000M | 97.20M | -5.80000M | 4.80M |
| Change to netincome | 38.90M | 7.90M | 53.60M | 33.90M | 39.80M |
| Capital expenditures | 51.40M | 25.00M | 21.90M | 21.90M | 17.10M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -145.90000M | -42.60000M | -17.00000M | -17.00000M | -12.40000M |
| Stock based compensation | 0.50M | 5.20M | 11.50M | - | - |
| Other non cash items | 16.80M | 15.00M | 41.50M | 34.10M | 40.60M |
| Free cash flow | 25.90M | 159.40M | 99.50M | 99.50M | 38.90M |
Sector: Consumer Cyclical Industry: Footwear & Accessories
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
28 Jamestown Road, London, United Kingdom, NW1 7BY
| Name | Title | Year Born |
|---|---|---|
| Mr. Kenneth Wilson | CEO & Director | 1967 |
| Mr. Jon W. Mortimore | CFO & Director | NA |
| Mr. Geert Peeters | Chief Operating Officer | 1966 |
| Mr. Ronald Garricks | Chief Information Officer | NA |
| Ms. Emily Reichwald | Gen. Counsel & Company Sec. | NA |
| Ms. Meg Johnson | Chief Marketing Officer | NA |
| Ms. Sue Gannon | Chief HR Officer | NA |
| Mr. Lorenzo Moretti | Pres of EMEA | NA |
| Mr. Sean O'Neill | Chief Digital Officer | NA |
| Mr. Derek Chan | Pres of APAC | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.